Table 2.
Changes in the study parameters of the participants in placebo and curcumin group after three-month intervention period.
| Outcome Measures | Treatment Group | Mean Change | p Value | Mean Difference between Treatment Groups | p Value |
|---|---|---|---|---|---|
| Body weight (kg) | Placebo | 0.64 ± 0.4 | 0.1731 | ||
| Curcumin | −0.1 ± 0.4 | 0.8272 | −0.7 ± 0.6 | 0.2292 | |
| Muscle mass (kg) | Placebo | 0.1 (0.1) | 0.8902 | ||
| Curcumin | 0.25 (0.7) | 0.4440 | 0.1(0.8) | 0.5257 | |
| Body fat mass (kg) | Placebo | 0.1 (0.4) | 0.7577 | ||
| Curcumin | −0.85 (0.9) | 0.8487 | −0.5 (2.1) | 0.3478 | |
| Body mass index (kg/m2) | Placebo | 0.20 (0.2) | 0.1945 | ||
| Curcumin | 0.03 (0.2) | 0.8296 | 0 (0.7) | 0.3573 | |
| Waist circumference (cm) | Placebo | 0.87 ± 0.7 | 0.2258 | ||
| Curcumin | −0.10 ± 0.8 | 0.8940 | −0.1 ± 1.0 | 0.3557 | |
| Percent body fat (%) | Placebo | 0.5 (1.8) | 0.4388 | ||
| Curcumin | −0.6 (1.6) | 0.5980 | 0 (2) | 0.7699 | |
| Fasting glucose (mmol/L) | Placebo | −0.06 ± 0.1 | 0.3625 | ||
| Curcumin | −0.07 ± 0.1 | 0.6041 | −0.004 ± 0.1 | 0.9747 | |
| Fasting serum insulin (µIU/L) | Placebo | 0.1 ± 0.4 | 0.8251 | ||
| Curcumin | −1.9 ± 0.6 | 0.0076 | −2.0 ± 0.4 | 0.0115 | |
| Dietary intakes (kj) | Placebo | −134.5 ± 479.2 | 0.7830 | ||
| Curcumin | 298.4 ± 487.9 | 0.5520 | −433.0 ± 686.6 | 0.5338 | |
| Physical activity (Metabolic equivalent-minute/week) | Placebo | −473 (3880) | 0.2202 | ||
| Curcumin | 104.5 (1508) | 0.6249 | 0 (2618) | 0.2386 |
Data are presented as mean ± SEM or median (IQR) as appropriate. p-values represent the significant differences with-in and between the groups.